A 12-week, Multi-Center, Randomized Double-Blind, Active Control Parallel Group Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Trial Profile

A 12-week, Multi-Center, Randomized Double-Blind, Active Control Parallel Group Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Mar 2013

At a glance

  • Drugs Aliskiren/valsartan (Primary) ; Amlodipine; Chlortalidone
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms VALENCIA
  • Sponsors Novartis
  • Most Recent Events

    • 01 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
    • 01 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top